Latest Cellectar Biosciences Inc. (CLRB) Headlines
Post# of 58
Posted On: 03/10/2014 8:35:15 PM
Latest Cellectar Biosciences Inc. (CLRB) Headlines
Cellectar Announces Initiation of Phase II Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
GlobeNewswire - Tue Mar 04, 7:01AM CST
Cellectar Biosciences, Inc. (OTCQX:CLRB) a biopharmaceutical company developing innovative agents for the detection and treatment of cancer, announced enrollment of the first patient in its Phase II imaging trial of I-124-CLR1404 in patients with glioblastoma.
Cellectar Announces Initiation of Phase II Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
GlobeNewswire - Tue Mar 04, 7:01AM CST
Cellectar Biosciences, Inc. (OTCQX:CLRB) a biopharmaceutical company developing innovative agents for the detection and treatment of cancer, announced enrollment of the first patient in its Phase II imaging trial of I-124-CLR1404 in patients with glioblastoma.
(0)
(0)Cellectar Biosciences, Inc. (CLRB) Stock Research Links
Scroll down for more posts ▼